BionTech releases “vaccine provider” after Taiwan humbled a deal collapse – expected China is involved
Biontec releases “vaccine for” – Reuters and Straits Times Report Feb. 18 on progress of the COVID-19 vaccine purchase plan. Taiwan Which previously Mr. Chen Shizhong Minister of Public Health Taiwan Stated that the procurement negotiations Pfizer-Bion Tech vaccine That is jointly developed between Pfizer in the United States. And the German company Biotech, 5 million doses in the final failed. Although Chen does not directly blame the Chinese government. But it said it believed outside intervention and made the deal to buy the vaccine out of hope.
Recently, Biontech announced via email on Wednesday evening, February 17 local time. It is important to note that the company plans to supply the vaccine to Taiwan. Negotiations are still underway. And Biontec will announce its progress once again.
“Biontec is committed to helping people around the world end the spread of disease. And we intend to provide Taiwan with the vaccine as part of our global commitment, ”Biontec said in a statement.
Biontec has reached an agreement with China’s Shanghai Foson Pharmaceutical Group to produce and distribute the COVID-19 vaccine. At Biontec, developed using mRNA technology in Mainland China, Hong Kong, Macao and Taiwan by Shanghai Foson Pharmaceuticals. Agreed to pay a license fee of up to US $ 85 million or approximately 2,550 million baht and invest more than 1,500 million baht in BionTech.